Valuation: Dishman Carbogen Amcis Limited

Capitalization 2.04TCr 21Cr 19Cr 17Cr 16Cr 30Cr 30Cr 201.97Cr 79Cr 985.45Cr 80Cr 79Cr 3.43TCr P/E ratio 2024
-24.1x
P/E ratio 2025 1,054x
Enterprise value 3.91TCr 41Cr 36Cr 33Cr 31Cr 57Cr 58Cr 387.84Cr 150.94Cr 1.89TCr 154.18Cr 150.83Cr 6.58TCr EV / Sales 2024
2.13x
EV / Sales 2025 1.95x
Free-Float
30.7%
Yield 2024 *
-
Yield 2025 -
1 day-1.07%
1 week-2.48%
Current month-2.48%
1 month+2.01%
3 months+15.31%
6 months-14.78%
Current year-23.31%
1 week 188.9
Extreme 188.9
202
1 month 173.8
Extreme 173.8
224.4
Current year 128.5
Extreme 128.5
267
1 year 128.5
Extreme 128.5
321.95
3 years 123.3
Extreme 123.3
321.95
5 years 80
Extreme 80
321.95
10 years 46.05
Extreme 46.05
396.4
Manager TitleAgeSince
Chief Executive Officer 40 07/02/2019
Director of Finance/CFO 44 28/11/2018
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 75 17/03/2017
Director/Board Member 40 17/03/2017
Director/Board Member - 13/11/2024
Change 5d. change 1-year change 3-years change Capi.($)
-1.07%-2.48%-30.55%+53.13% 31Cr
+0.55%+2.39%+47.77%+154.68% 1,00900Cr
+2.02%+3.30%+51.48%+47.03% 56TCr
+1.02%+4.37%+21.21%+66.03% 40TCr
+0.77%-0.67%+22.19%+12.23% 33TCr
+2.24%+0.41%+29.51%+17.50% 29TCr
+1.85%+0.14%+22.04%+30.54% 27TCr
+4.43%-3.11%-40.46%-47.48% 19TCr
+1.15%+3.80%+21.76%+57.55% 19TCr
-0.02%-3.92%+16.93%+66.19% 16TCr
Average +0.95%+0.80%+16.19%+45.74% 34.02TCr
Weighted average by Cap. +0.63%+1.96%+31.24%+70.11%

Financials

2024 2025
Net sales 2.62TCr 27Cr 24Cr 22Cr 21Cr 38Cr 39Cr 259.26Cr 100.9Cr 1.27TCr 103.07Cr 100.83Cr 4.4TCr 2.71TCr 28Cr 25Cr 23Cr 21Cr 40Cr 40Cr 268.75Cr 104.59Cr 1.31TCr 106.84Cr 104.52Cr 4.56TCr
Net income -153.45Cr -1.61Cr -1.39Cr -1.28Cr -1.2Cr -2.24Cr -2.28Cr -15Cr -5.92Cr -74Cr -6.05Cr -5.91Cr -258.07Cr 3.24Cr 3L 3L 3L 3L 5L 5L 32.11L 12.5L 1.57Cr 12.77L 12.49L 5.45Cr
Net Debt 1.88TCr 20Cr 17Cr 16Cr 15Cr 27Cr 28Cr 186.46Cr 73Cr 909.77Cr 74Cr 73Cr 3.16TCr 1.88TCr 20Cr 17Cr 16Cr 15Cr 27Cr 28Cr 185.87Cr 72Cr 906.94Cr 74Cr 72Cr 3.15TCr
Logo Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules such as specialty chemicals, vitamins and chemicals, and disinfectants. Its segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. The Marketable Molecules segment manufactures and supplies intermediates, quaternary compounds, specialty chemicals, and various products for pharmaceuticals and cosmetics. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom, and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., and others.
Employees
1,106
Date Price Change Volume
05/26/05 189.88 -1.07% 1,85,064
04/26/04 191.94 -1.63% 2,08,341
03/26/03 195.13 -1.99% 2,01,753
02/26/02 199.10 +1.78% 2,24,671
01/26/01 195.62 +0.47% 2,15,093

Annual profits - Rate of surprise